Literature DB >> 20360320

Performance-based measures of everyday function in mild cognitive impairment.

Terry E Goldberg1, Jeremy Koppel, Lynda Keehlisen, Erica Christen, Ute Dreses-Werringloer, Concepcion Conejero-Goldberg, Marc L Gordon, Peter Davies.   

Abstract

OBJECTIVE: The view that everyday function is preserved in mild cognitive impairment may be problematic. The objectives of this study were to determine the magnitude of impairment in everyday function in patients with mild cognitive impairment and Alzheimer's disease using a novel sensitive performance-based measure (the UCSD Performance-Based Skills Assessment; UPSA), contrast it with use of an informant-based measure (the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory; ADCS-ADL), and model the relationship between cognitive measures and the performance-based measure.
METHOD: Fifty cognitively normal elders, 26 patients who met criteria for amnestic mild cognitive impairment, and 22 patients who suffered from mild to moderate Alzheimer's disease were assessed on the UPSA, the ADCS-ADL, and a battery of neurocognitive tests.
RESULTS: Patients with mild cognitive impairment had significant impairments on the UPSA but not on the ADCS-ADL. The magnitude of the effect size between the cognitively healthy and the mild cognitive impairment group for the UPSA was large (d=0.86). A strong and significant relationship was observed between cognitive performances in speed (R(2)=0.37), episodic memory (R(2)=0.10), and semantic processing (R(2)=0.03) and UPSA score using multiple regression models. The psychometric properties of the UPSA were acceptable, as were its sensitivity and specificity in contrasts between cognitively normal elders and patients with mild cognitive impairment and between the latter group and patients with Alzheimer's disease.
CONCLUSIONS: These findings indicate that performance-based measures of function may be a sensitive tool in studies of Alzheimer's disease and mild cognitive impairment and suggest the need for a reconceptualization of the relationship between cognition and function in mild cognitive impairment so that they can be usefully aligned.

Entities:  

Mesh:

Year:  2010        PMID: 20360320      PMCID: PMC2900829          DOI: 10.1176/appi.ajp.2010.09050692

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

Review 1.  The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association.

Authors:  Donald R Royall; Edward C Lauterbach; Daniel Kaufer; Paul Malloy; Kerry L Coburn; Kevin J Black
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

2.  The measurement of everyday cognition (ECog): scale development and psychometric properties.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Deborah Cahn-Weiner; William Jagust; Kathleen Baynes; Charles Decarli
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

3.  Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

Authors:  Gregory A Jicha; Joseph E Parisi; Dennis W Dickson; Kris Johnson; Ruth Cha; Robert J Ivnik; Eric G Tangalos; Bradley F Boeve; David S Knopman; Heiko Braak; Ronald C Petersen
Journal:  Arch Neurol       Date:  2006-05

4.  Neuropathologic features of amnestic mild cognitive impairment.

Authors:  Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Kris A Johnson; David S Knopman; Bradley F Boeve; Gregory A Jicha; Robert J Ivnik; Glenn E Smith; Eric G Tangalos; Heiko Braak; Emre Kokmen
Journal:  Arch Neurol       Date:  2006-05

5.  Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.

Authors:  P A Boyle; R S Wilson; N T Aggarwal; Y Tang; D A Bennett
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

6.  Restriction in complex activities of daily living in MCI: impact on outcome.

Authors:  K Pérès; V Chrysostome; C Fabrigoule; J M Orgogozo; J F Dartigues; P Barberger-Gateau
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

7.  PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Authors:  N M Kemppainen; S Aalto; I A Wilson; K Någren; S Helin; A Brück; V Oikonen; M Kailajärvi; M Scheinin; M Viitanen; R Parkkola; J O Rinne
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

Review 8.  Long-term memory impairment in patients with focal epilepsy.

Authors:  Christian Hoppe; Christian E Elger; Christoph Helmstaedter
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

9.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen
Journal:  Brain       Date:  2008-02-07       Impact factor: 13.501

10.  Development of a brief scale of everyday functioning in persons with serious mental illness.

Authors:  Brent T Mausbach; Phillip D Harvey; Sherry R Goldman; Dilip V Jeste; Thomas L Patterson
Journal:  Schizophr Bull       Date:  2007-03-06       Impact factor: 9.306

View more
  54 in total

Review 1.  Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Cutter A Lindbergh; Rodney K Dishman; L Stephen Miller
Journal:  Neuropsychol Rev       Date:  2016-07-08       Impact factor: 7.444

2.  Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief.

Authors:  Lea Vella; Thomas L Patterson; Philip D Harvey; Margaret McNamara McClure; Brent T Mausbach; Michael J Taylor; Elizabeth W Twamley
Journal:  Psychiatry Res       Date:  2017-06-12       Impact factor: 3.222

3.  Mild Cognitive Impairment and Changes in Everyday Function Over Time: The Importance of Evaluating Both Speed and Accuracy.

Authors:  Caroline L Lassen-Greene; Kayla Steward; Ozioma Okonkwo; Ellen Porter; Michael Crowe; David E Vance; H Randall Griffith; Karlene Ball; Daniel C Marson; Virginia G Wadley
Journal:  J Geriatr Psychiatry Neurol       Date:  2017-07       Impact factor: 2.680

Review 4.  Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies.

Authors:  Terry E Goldberg; Richard S E Keefe; Robert S Goldman; Delbert G Robinson; Philip D Harvey
Journal:  Neuropsychopharmacology       Date:  2010-01-20       Impact factor: 7.853

5.  Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to Dementia.

Authors:  Davangere P Devanand; Xinhua Liu; Patrick J Brown
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

6.  Everyday functioning and cognitive correlates in healthy older adults with subjective cognitive concerns.

Authors:  Courtney McAlister; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2016-05-31       Impact factor: 3.535

7.  [Mild neurocognitive disorder - a disease? For].

Authors:  F Jessen
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

8.  Verbal prompting to improve everyday cognition in MCI and unimpaired older adults.

Authors:  Kelsey R Thomas; Michael Marsiske
Journal:  Neuropsychology       Date:  2013-11-11       Impact factor: 3.295

9.  Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?

Authors:  Gad A Marshall; Rebecca E Amariglio; Reisa A Sperling; Dorene M Rentz
Journal:  Neurodegener Dis Manag       Date:  2012-10-01

10.  Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

Authors:  A S Atkins; I Stroescu; N B Spagnola; V G Davis; T D Patterson; M Narasimhan; P D Harvey; R S E Keefe
Journal:  J Prev Alzheimers Dis       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.